查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011012

數位病理市場：按類型、產品類型、應用和最終用戶分類－2026-2032年全球市場預測

Digital Pathology Market by Type, Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

數位病理學市場預計到 2025 年將達到 14.4 億美元，到 2026 年將成長到 16.6 億美元，到 2032 年將達到 40.9 億美元，複合年成長率為 16.05%。

主要市場統計數據
基準年 2025 14.4億美元
預計年份：2026年 16.6億美元
預測年份 2032 40.9億美元
複合年成長率 (%) 16.05%

全面概述成像硬體、分析軟體和資料基礎設施如何整合，進而重塑診斷工作流程和調查流程。

數位病理學已從實驗輔助手段發展成為現代診斷和研究基礎設施的重要組成部分。本文將此領域定位為影像處理硬體、先進軟體平台以及可擴展儲存和通訊系統的融合，這些技術共同重塑了組織資料的採集、分析和說明方式。這些技術進步與不斷變化的臨床工作流程、監管要求以及遠端協作的需求相交織，重新定義了病理學家、檢查室管理人員和資訊學團隊在提供診斷準確性和促進轉化研究方面的角色。

分析正在加速病理服務領域採用新技術、新監管和新臨床趨勢，並重塑營運模式。

在技​​術創新、政策轉變和臨床範式演進的驅動下，數位病理學領域正經歷著一場變革。掃描儀光學技術的進步、高通量切片數位化以及安全通訊系統的改進降低了技術門檻，使得數位化。

對近期關稅調整如何影響病理生態系統內的籌資策略、供應商選擇和供應鏈韌性進行詳細分析。

美國近期關稅調整為影像系統、掃描器及周邊設備的籌資策略引入了新的變數，影響了全球供應鏈中多個供應商類別的決策。採購團隊和供應鏈經理正在採取一系列措施，例如重新評估採購區域、調整預估的總到岸成本，以及尋找替代供應商，以保障計劃進度和資本計畫。這些調整正在影響設備選用、供應商談判以及檢查室現代化改造的進程。

透過對產品類型、工作流程階段、臨床應用和最終用戶概況進行詳細的細分洞察，可以製定有針對性的部署和商業化計劃。

細分市場分析揭示了需求促進因素和部署模式在產品線、臨床工作流程、應用和最終用戶中的集中位置，從而為有針對性的部署和商業化策略提供了框架。從產品角度來看，市場涵蓋通訊系統、掃描器、軟體和儲存系統，其中軟體進一步細分為雲端部署和本地部署。這種細分突顯了買家優先事項的差異：通訊系統和儲存系統與基礎設施投資密切相關，掃描器是資本設備的重點，而軟體則傾向於決定工作流程的協調和分析能力。

區域市場動態和部署模式闡明了全球主要地區的策略機會和營運考量。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管參與和夥伴關係模式，為供應商和醫療機構創造了差異化的策略機會。在美洲，強大的研究基礎設施和蓬勃發展的商業市場正在推動先進掃描器、人工智慧驅動的分析和企業級影像管理技術的早期應用。同時，報銷框架和監管核准流程正在影響檢驗重點和臨床部署計劃。該地區的相關人員通常優先考慮與現有實驗室資訊系統 (LIS) 的整合以及處理能力的最佳化，以支援高容量診斷工作流程。

深入了解影響整個數位病理生態系統採購決策和臨床整合的供應商策略、夥伴關係模式和功能差異化。

產業巨頭們正在整合各自的技術棧，投資於互通性，並拓展服務模式，以掌握診斷、研發和藥物開發領域的機會。領先的供應商正透過整合高解析度掃描器、強大的影像管理平台和高級分析功能的端到端解決方案來脫穎而出，而新興的專業軟體供應商則專注於細分領域的分析、符合監管要求的AI檢驗以及雲端原生協作工具。這些策略舉措反映了生態系統正朝著基於平台的產品和服務以及連接臨床和商業應用場景的夥伴關係關係而成熟。

制定切實可行的分階段策略，用於採購、檢驗和整合數位病理能力，同時確保互通性、管治和人才準備。

產業領導者應採取務實的分階段方法來實施數位病理學，以平衡臨床檢驗、工作流程整合和變更管理。首先，應確定與組織優先事項相符的高影響力用例，例如診斷亞專科和調查計畫，並制定基於證據的檢驗計劃，以證明其臨床效用和營運效益。同時，在選擇供應商時，互通性和資料管治應是至關重要的要求，以確保長期柔軟性並符合當地法規。

本研究採用嚴謹的混合方法研究設計，結合一手訪談、技術評估和二手文獻，以類似三角測量的方式檢驗趨勢和細分框架。

本調查方法結合了質性訪談、技術環境映射和二手資訊的交叉檢驗，旨在建構穩健的分析證據基礎。透過與臨床負責人、實驗室管理人員、供應商和監管專家進行結構化討論，我們獲得了關於技術採納促進因素、檢驗障礙和採購考慮等方面的主要見解。同時，技術評估檢驗了掃描器的規格、軟體架構以及儲存和通訊模式，以識別功能差異。這種多方面的方法確保了研究結果既能反映實際操作情況，又能反映技術發展趨勢。

前瞻性的綜合分析，將技術能力、臨床檢驗和營運準備相結合，指導永續實施和可衡量的影響。

數位病理學正處於轉折點，技術能力、臨床需求和組織準備度在此交匯融合，為改進診斷和加速調查創造了永續的機會。結論整合了以下幾個關鍵主題：互通軟體架構的重要性、檢驗的分析方法日益成長的相關性，以及應對供應鏈差異和區域監管細微差別的策略採購的必要性。這些要素共同構成了一份切實可行的藍圖，供希望從其在數位病理學領域的投資中獲得可衡量成果的利害關係人相關人員。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：數位病理市場：按類型分類

  • 人類病理學
  • 獸醫病理學

第9章：數位病理市場：依產品分類

  • 硬體
    • 展示
      • 市售產品
      • 醫用級
      • 專業級
    • 掃描器
      • 明場掃描儀
      • 螢光掃描儀
    • 儲存系統
  • 服務
    • 諮詢及實施服務
    • 維護和支援服務
    • 培訓服務
  • 軟體
    • 影像管理系統（IMS）
    • 檢查資訊系統（LIS）
    • 影像存檔和通訊系統（PACS）

第10章：數位病理市場：依應用領域分類

  • 生物標記發現
  • 疾病診斷
    • 感染疾病
    • 神經病學
    • 腫瘤學
  • 藥物發現與開發
  • 遠距病理診斷
  • 毒性測試
  • 培訓和教育

第11章 數位病理市場：依最終用戶分類

  • 學術和研究機構
  • 合約研究機構
  • 政府和監管機構
  • 醫院/診斷檢查室
  • 製藥和生物技術公司

第12章 數字病理市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 數位病理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 數位病理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國數位病理市場

第16章：中國數位病理市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Akoya Biosciences
  • Charles River Laboratories
  • Corista LLC
  • Danaher Corporation
  • Deep Bio Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Hamamatsu Photonics KK
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Mikroscan Technologies, Inc.
  • Motic
  • Nikon Corporation
  • Olympus Corporation
  • OptraSCAN Inc.
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Quest Diagnostics Incorporated
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.
Product Code: MRR-433498411CFD

The Digital Pathology Market was valued at USD 1.44 billion in 2025 and is projected to grow to USD 1.66 billion in 2026, with a CAGR of 16.05%, reaching USD 4.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.44 billion
Estimated Year [2026] USD 1.66 billion
Forecast Year [2032] USD 4.09 billion
CAGR (%) 16.05%

A comprehensive overview of how imaging hardware, analytics software, and data infrastructure converge to reshape diagnostic workflows and research pipelines

Digital pathology has evolved from an experimental adjunct to an integral component of contemporary diagnostic and research infrastructures. This introduction frames the field as a convergence of imaging hardware, sophisticated software platforms, and scalable storage and communication systems that collectively reshape how tissue-based data are acquired, analyzed, and managed. These technological advances intersect with changes in clinical workflows, regulatory expectations, and demands for remote collaboration, thereby redefining the roles of pathologists, laboratory managers, and informatics teams in delivering diagnostic certainty and enabling translational research.

As adoption accelerates, stakeholders face both opportunities and integration challenges. Implementation requires alignment across image acquisition modalities, image analysis algorithms, and enterprise-grade image management systems, with software options spanning cloud-based and on-premise deployments to meet diverse institutional constraints. Consequently, decision-makers must weigh interoperability, data governance, and clinical validation pathways alongside operational priorities such as throughput, turnaround times, and workforce upskilling. This introduction sets a foundation for subsequent sections by outlining the core components, emergent drivers, and pragmatic considerations that will guide strategic planning and investment in digital pathology initiatives.

An analysis of emerging technological, regulatory, and clinical dynamics that are accelerating adoption and reshaping operational models across pathology services

The landscape of digital pathology is undergoing transformative shifts driven by technological innovation, policy recalibration, and evolving clinical paradigms. Advances in scanner optics, high-throughput slide digitization, and secure communication systems have reduced technical friction and enabled broader decentralization of pathology services. At the same time, image analysis has progressed from basic morphometric tools to AI-enabled algorithms capable of extracting multiplexed phenotypic and spatial biomarkers, thereby expanding the clinical and research use cases of digitized histology.

Concurrently, the maturation of software ecosystems, including both cloud-based solutions and on-premise platforms, has introduced new modalities of deployment and scale. Cloud options accelerate collaboration across institutions and support centralized analytics while on-premise systems continue to appeal for latency-sensitive workflows and strict data residency requirements. Moreover, shifting regulatory frameworks and growing emphasis on telepathology and remote consultation have propelled adoption in settings that previously relied solely on conventional microscopy. Taken together, these shifts are not isolated; they interact to create a feedback loop where improved algorithms demand richer data, and richer data prompt investments in storage and communication, thereby accelerating the next wave of capability development and clinical integration.

A focused assessment of how recent tariff adjustments have reshaped procurement strategies, vendor sourcing decisions, and supply chain resilience in the pathology ecosystem

Recent tariff changes in the United States have introduced a new variable into procurement strategies for imaging systems, scanners, and ancillary hardware, and they have influenced global supply chain decisions across multiple vendor categories. Procurement teams and supply chain managers are responding by reassessing sourcing geographies, recalibrating total landed cost assumptions, and exploring alternative suppliers to protect project timelines and capital planning. These adjustments have implications for equipment selection, vendor negotiations, and the cadence of laboratory modernization efforts.

In parallel, the tariffs have prompted suppliers to revisit manufacturing footprints and component sourcing strategies to mitigate exposure; some vendors are accelerating diversification of production sites, while others are absorbing short-term cost impacts to preserve market access. For purchasers, this environment underscores the importance of flexible contracting clauses and longer lead-time visibility to avoid disruption. Moreover, the tariff context amplifies incentives to evaluate software-centric solutions and cloud-based services where physical hardware exposure is reduced, though this shift also raises considerations around data sovereignty and recurring operating expenditures. Overall, the tariff changes create an imperative for strategic procurement that balances cost, vendor resilience, and long-term technical requirements.

Deep segmentation insights that align product categories, workflow stages, clinical applications, and end-user profiles to inform targeted deployment and commercialization planning

Segmentation analysis reveals where demand drivers and adoption patterns concentrate across product lines, clinical workflows, applications, and end users, providing a framework for targeted deployment and commercialization strategies. From a product perspective, the market encompasses communication systems, scanners, software, and storage systems, with software further differentiated into cloud-based and on-premise offerings; this delineation highlights distinct buyer priorities, where communication systems and storage often align with infrastructure investments, scanners serve as capital equipment focal points, and software dictates workflow orchestration and analytics capabilities.

When viewed through the lens of workflow, the ecosystem spans image acquisition, image analysis, and image management, which together form the core operational pipeline from specimen digitization to actionable insight. Application-driven segmentation illuminates strategic value pools including biomarker discovery, disease diagnosis, drug development, telepathology, toxicology studies, and training and education, with disease diagnosis further refined into infectious diseases, neurology, and oncology, each demanding specialized analytic approaches and validation pathways. Finally, end-user segmentation differentiates academic and research institutes, contract research organizations, government and regulatory bodies, hospitals and diagnostic labs, and pharmaceutical and biotechnology companies, reflecting variations in procurement cycles, regulatory priorities, and integration complexity. By integrating these segmentation dimensions, stakeholders can prioritize investments that align with institutional capabilities and unmet clinical needs.

Regional market dynamics and adoption patterns that delineate strategic opportunities and operational considerations across major global geographies

Regional dynamics influence adoption patterns, regulatory engagement, and partnership models across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating differentiated strategic opportunities for vendors and healthcare organizations. In the Americas, strong research infrastructure and an active commercial market foster early uptake of advanced scanners, AI-enabled analysis, and enterprise-grade image management, while reimbursement frameworks and regulatory pathways shape validation priorities and clinical deployment timelines. Stakeholders here often prioritize integration with existing laboratory information systems and throughput optimization to support high-volume diagnostic workflows.

Across Europe, the Middle East & Africa, and Asia-Pacific, diverse market maturities and regulatory environments create both challenges and opportunities. Some countries within Europe and Asia-Pacific demonstrate rapid adoption driven by national digital health initiatives and investments in telepathology to address workforce shortages, whereas parts of the Middle East & Africa emphasize capacity building and partnerships with academic centers. In Asia-Pacific, expanding clinical trial activity and a growing biotech sector support demand for solutions tailored to drug development and biomarker discovery. Transitional approaches that account for regional data governance, interoperability standards, and local talent development prove essential for successful implementations in each geography.

Insights into vendor strategies, partnership models, and capability differentiation that influence procurement decisions and clinical integration across the digital pathology ecosystem

Key industry players are consolidating technology stacks, investing in interoperability, and expanding service models to capture opportunities across diagnostics, research, and drug development. Leading vendors are differentiating through end-to-end offerings that combine high-resolution scanners, robust image management platforms, and advanced analytics, while an emerging cohort of specialized software providers focuses on niche analytics, regulatory-grade AI validation, and cloud-native collaboration tools. These strategic moves reflect a maturation of the ecosystem toward platform-based delivery and partnerships that bridge clinical and commercial use cases.

Partnership dynamics have also shifted, with alliances forming between imaging hardware manufacturers and software companies to accelerate validated workflows and streamline buyer journeys. Concurrently, service providers and contract research organizations are integrating digital pathology capabilities to offer higher-value preclinical and clinical research services. For buyers, vendor selection increasingly prioritizes demonstrated interoperability, certification pathways, and the ability to deliver reproducible, explainable analytics that align with regulatory expectations. Vendors that can demonstrate clinical validation, offer flexible deployment models, and provide comprehensive support for workflow integration will maintain competitive advantage as the market evolves.

Actionable, phased strategies for procuring, validating, and integrating digital pathology capabilities while safeguarding interoperability, governance, and workforce readiness

Industry leaders should adopt a pragmatic, phased approach to digital pathology adoption that balances clinical validation, workflow integration, and change management. Begin by identifying high-impact use cases that align with institutional priorities, such as diagnostic subspecialties or research programs, and establish evidence-based validation plans that demonstrate clinical utility and operational benefit. Simultaneously, make interoperability and data governance non-negotiable criteria when selecting vendors to ensure long-term flexibility and compliance with regional regulations.

Leaders should also invest in workforce development and cross-disciplinary collaboration to maximize the value of digitized slides and analytics. Training programs that combine pathology expertise with data science literacy will accelerate algorithm adoption and ensure responsible interpretation of AI outputs. From a procurement perspective, explore flexible contracting models that mitigate tariff exposure and enable staged rollouts, while considering a balance between cloud-based and on-premise deployments to meet latency, security, and cost objectives. Finally, prioritize partnerships that offer comprehensive implementation support, including integration with laboratory information systems and tailored professional services to expedite validation and adoption across clinical and research settings.

A rigorous mixed-methods research design that triangulates primary interviews, technical assessments, and secondary literature to validate trends and segmentation frameworks

The research methodology combines qualitative interviews, technology landscape mapping, and cross-validation of secondary sources to build a robust evidence base for analysis. Structured discussions with clinical leaders, laboratory directors, vendors, and regulatory experts provided primary insights into adoption drivers, validation hurdles, and procurement considerations, while technical assessments examined scanner specifications, software architectures, and storage and communication paradigms to understand capability differentials. This multipronged approach ensures that findings reflect both operational realities and technological trajectories.

Secondary analysis supplemented primary inputs with a systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available vendor materials to contextualize trends and technological performance. Comparative assessments identified patterns in deployment models, interoperability approaches, and clinical use cases, while synthesis workshops reconciled divergent perspectives and validated segmentation frameworks. Throughout the process, methodological rigor emphasized triangulation of sources, transparency about assumptions, and continuous stakeholder validation to enhance credibility and relevance for decision-makers across clinical, research, and commercial domains.

A forward-looking synthesis that aligns technological capability, clinical validation, and operational readiness to guide sustained adoption and measurable impact

Digital pathology stands at an inflection point where technological capability, clinical need, and organizational readiness converge to create durable opportunities for improved diagnostics and accelerated research. The conclusion synthesizes core themes: the centrality of interoperable software architectures, the growing importance of validated analytics, and the imperative for strategic procurement that accommodates supply chain volatility and regional regulatory nuance. Together, these elements shape a pragmatic roadmap for stakeholders seeking to derive measurable outcomes from digital pathology investments.

Looking ahead, success will hinge on aligning clinical validation with workflow redesign, investing in human capital, and choosing partners that can deliver integrated solutions and sustained implementation support. The most successful organizations will treat digital pathology not as a stand-alone technology purchase but as a platform for continuous improvement that spans diagnostics, translational research, and drug development. By maintaining a focus on reproducibility, explainability, and governance, institutions can translate technological promise into tangible clinical and scientific advances while managing operational and regulatory complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital Pathology Market, by Type

  • 8.1. Human Pathology
  • 8.2. Veterinary Pathology

9. Digital Pathology Market, by Product

  • 9.1. Hardware
    • 9.1.1. Displays
      • 9.1.1.1. Consumer off the Shelf
      • 9.1.1.2. Medical Grade
      • 9.1.1.3. Professional Grade
    • 9.1.2. Scanners
      • 9.1.2.1. Brightfield Scanners
      • 9.1.2.2. Fluorescence Scanners
    • 9.1.3. Storage Systems
  • 9.2. Services
    • 9.2.1. Consulting & Implementation Services
    • 9.2.2. Maintenance & Support Services
    • 9.2.3. Training Services
  • 9.3. Software
    • 9.3.1. Image Management Systems (IMS)
    • 9.3.2. Laboratory Information Systems (LIS)
    • 9.3.3. Picture Archiving and Communication Systems (PACS)

10. Digital Pathology Market, by Application

  • 10.1. Biomarker Discovery
  • 10.2. Disease Diagnosis
    • 10.2.1. Infectious Diseases
    • 10.2.2. Neurology
    • 10.2.3. Oncology
  • 10.3. Drug Discovery & Development
  • 10.4. Telepathology
  • 10.5. Toxicology Studies
  • 10.6. Training & Education

11. Digital Pathology Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations
  • 11.3. Government & Regulatory Bodies
  • 11.4. Hospitals & Diagnostic Labs
  • 11.5. Pharmaceutical & Biotechnology Companies

12. Digital Pathology Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Digital Pathology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Digital Pathology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Digital Pathology Market

16. China Digital Pathology Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3DHISTECH Ltd.
  • 17.6. Aiforia Technologies PLC
  • 17.7. Akoya Biosciences
  • 17.8. Charles River Laboratories
  • 17.9. Corista LLC
  • 17.10. Danaher Corporation
  • 17.11. Deep Bio Inc.
  • 17.12. Epredia
  • 17.13. F. Hoffmann-La Roche Ltd.
  • 17.14. FUJIFILM Holdings Corporation
  • 17.15. General Electric Company
  • 17.16. Hamamatsu Photonics K.K.
  • 17.17. Huron Digital Pathology
  • 17.18. Indica Labs
  • 17.19. Koninklijke Philips N.V.
  • 17.20. Laboratory Corporation of America Holdings
  • 17.21. Mikroscan Technologies, Inc.
  • 17.22. Motic
  • 17.23. Nikon Corporation
  • 17.24. Olympus Corporation
  • 17.25. OptraSCAN Inc.
  • 17.26. Pathcore Inc.
  • 17.27. PathPresenter Corporation
  • 17.28. PerkinElmer, Inc.
  • 17.29. Proscia, Inc.
  • 17.30. Quest Diagnostics Incorporated
  • 17.31. Sectra AB
  • 17.32. Visiopharm A/S
  • 17.33. Xybion Digital Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 215. GCC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 263. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)